KALEIDO BIOSCIENCES INC (KLDO) Stock News
NASDAQ:KLDO - Nasdaq - US4833471000 - Common Stock
KLDO Latest News, Press Relases and Analysis
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting season.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
The biggest pre-market stock movers for Thursday are ready and waiting so let's see what's moving the market this morning!
Why Is Creatd (CRTD) Stock Up Today?
Creatd (CRTD) stock is heading higher on Wednesday following news of a deal for wellness beverage subsidiary Dune Glow Remedy.
Dear KLDO Stock Fans, Mark Your Calendars for April 28
Kaleido Biosciences (KLDO) stock is soaring on Wednesday but anyone considering a stake in the company will want to keep an eye on April 28.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Rise and shine, investor! It's time to start off another week of trading with the biggest pre-market stock movers for Monday!
Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn’s and Colitis Congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated,...
Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions
LEXINGTON, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated,...
Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer
LEXINGTON, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated,...
Kaleido Biosciences Reports Third Quarter 2021 Financial Results
--Achieved primary objective of safety and tolerability in clinical study evaluating KB295 in mild-to-moderate ulcerative colitis; meaningful reduction...
Down 23.6% in 4 Weeks, Here's Why Kaleido Biosciences, Inc. (KLDO) Looks Ripe for a Turnaround
Kaleido Biosciences, Inc. (KLDO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.